DiaMedica Therapeutics (NASDAQ:DMAC) Stock Price Up 1.1%
Related Articles
-
AXS Investments LLC Reduces Stock Holdings in Meta Platforms, Inc. (NASDAQ:META)
AXS Investments LLC cut its position in Meta Platforms, Inc. (NASDAQ:META – Free Report) by 0.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,471 shares of the social networking company’s stock after selling 64 shares during the quarter. Meta Platforms […]
-
Lam Research stock climbs on $10B stock buyback, 10-for-1 stock split (NASDAQ:LRCX)
Lam Research announces $10 billion share repurchase authorization and a forward stock split, leading to a 5% jump in premarket shares.
-
Oxler Private Wealth LLC Has $6.63 Million Stake in Meta Platforms, Inc. (NASDAQ:META)
Oxler Private Wealth LLC lessened its stake in Meta Platforms, Inc. (NASDAQ:META – Free Report) by 35.3% in the fourth quarter, HoldingsChannel reports. The fund owned 18,743 shares of the social networking company’s stock after selling 10,247 shares during the period. Meta Platforms makes up about 5.5% of Oxler Private Wealth LLC’s portfolio, making the […]